|
| The sample is, after acidification and addition of labeled internal standards, injected and analyzed by using high pressure liquid chromatography and accurate mass mass-selective detection. The surface ofthe peaks in the chromatogram is a measure of the concentration. |
|
|
| Reporting limit: | 0.01 - 0.05 μg/l, parameter and matrix dependent |
| Measurement uncertainty: | 70% |
| Sustainability: | 6 days
|
| Sampling bottle: | Glass
, brown
, 100 ml
(fill up to the neck of the bottle)
|
|
| (RL = 0.01 μg/l) | carbamazepine; clarithromycin; metoprolol; propranolol; sotalol; sulfametoxazole; trimethoprim; amisulpride (not accreditated); citalopram (not accreditated); venlafaxine (not accreditated); 1,2,3-benzotriazole; @4+5-methylbenzotriazol |
| (RL = 0.02 μg/l) | diclofenac; gabapentine; irbesartan; furosemide (not accreditated); candesartan (not accreditated) |
| (RL = 0.05 μg/l) | hydrochlorothiazide; azitromycine (not accreditated) |
